Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA
Performance Review
 

Clinical Measures for Health Center Grantee Performance Reviews –
Calendar Year 2006


Performance Measure: # 7a   Activity Code(s): H 80  
Percentage of patients with abnormal cervical cancer (Pap smear) screening results, for which referral and/or treatment has been initiated within 30 days.
 
Definition:
Numerator:

Persons in the denominator for whom follow-up assessment – such as notification, referral, scheduling of follow up appointment, treatment, etc. – have been documented and initiated within 30 days of test completion.
Denominator: Total number of patients with an abnormal Pap screening test during calendar year.
Unit & Text: numerator count/denominator count x 100 = %
 
National Benchmark:

There are no benchmarks for follow up of abnormal reports.

Health Disparities Collaborative benchmark:
95% goal for having documented notification of results within 30days of test completion.
http://healthdisparities.net/hdc/Library/7-19-2005.7366/CancerMeasures_Mar05.pdf

HEDIS Annual Report on Health Care Quality: 2005
http://www.ncqa.org/docs/SOHCQ_2005.pdf (page 31)

Data Sources
and Data Issues:

From registry or EHR/EMR if available.

If chart audit, then sample from the sample frame of persons meeting denominator criteria.

 
Background/significance of measure:

Cancer is the second leading cause of death in the United States, exceeded only by heart disease. Breast cancer is one of the most common types of cancer among American women. There were an estimated 217,440 new cases of breast cancer and 40,580 deaths from breast cancer in 2004.1

Although there continues to be debate and controversy concerning optimal guidelines for mammography screening, the National Cancer Institute, the American Cancer Society, and most medical specialty organizations concur that early detection by regular mammograms is associated with a reduced risk of breast cancer mortality for women aged 40 and over. (Journal of Women's Health, Jan 2003) & (2). Women whose breast cancer is identified early are more likely to require less intensive therapy. As with many cancers, breast cancer detected in its earliest, pre-invasive stage costs significantly less than cancer detected in later stages. In the U.S., breast cancer treatment costs exceed $7 billion per year.3

For more info on Cancer screening see:
http://www.cancer.gov/cancertopics/screening &
http://www.cancer.gov/cancertopics/pdq/screening

For information on this measure, see:
http://healthdisparities.net/hdc/Library/7-19-2005.7366/CancerMeasures_Mar05.pdf
Health Disparities Collaborative recommends screening mammography >_ 42 years every 2years.

For information on treatment, see:
http://www.cancer.gov/cancertopics/treatment &
http://www.cancer.gov/cancertopics/pdq/adulttreatment

HEDIS Annual Report on Health Care Quality: 2005
http://www.ncqa.org/docs/SOHCQ_2005.pdf (page 30)
Medscape: Factors Affecting Follow-Up Among Low-Income Women with Breast Abnormalities
Posted 04/20/2004
http://www.medscape.com/viewarticle/473007

Breast Cancer Screening: See US Preventive Services Task Force: http://www.ahrq.gov/clinic/3rduspstf/breastcancer/brcanrr.pdf
USPSTF recommends screening mammography, with or without clinical breast examination (CBE), every 1-2 years for women >_ 40 years

Other guidelines and regulations:
Mammography Quality Standard Act (federal regulation):
Requires all women are to be notified of their mammogram results. . Radiology facilities are responsible for this notification.

Screening has been proven to prevent and/or ameliorate the course of a number of serious medical conditions. Early and regular screening for cancer is one of our most effective tools. Much suffering, disability as well as deaths can be avoided if more people were screened for cancer.
This measure examines the continuity of care and adherence to protocol at health centers for cancer screening and follow up. This includes provider education, patient outreach and health education, referral, appointment system, and other factors necessary to coordinate this process.
1. American Cancer Society. Cancer Facts & Figures 2004. 2004.
2. National Cancer Institute, National Institutes of Health. Cancer Facts: Screening
Mammograms. Last reviewed: May 3, 2002. http://cis.nci.nih.gov/fact/5_28.htm.
3. CDC fact sheet, 2004. http://www.cdc.gov/nccdphp/factsheets/prevention/cancer.htm.